David Roman
Stock Analyst at Goldman Sachs
(1.56)
# 2,280
Out of 4,479 analysts
11
Total ratings
100%
Success rate
5.44%
Average return
Main Sectors:
11 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BSX Boston Scientific | Initiates: Buy | $90 | $76.55 | +17.57% | 1 | May 30, 2024 | |
EW Edwards Lifesciences | Initiates: Buy | $107 | $91.23 | +17.29% | 1 | May 30, 2024 | |
SYK Stryker | Initiates: Neutral | $372 | $334.30 | +11.28% | 1 | May 30, 2024 | |
ISRG Intuitive Surgical | Initiates: Buy | $500 | $438.81 | +13.94% | 1 | May 30, 2024 | |
ABT Abbott Laboratories | Initiates: Buy | $121 | $103.20 | +17.25% | 1 | May 30, 2024 | |
BDX Becton, Dickinson and Company | Initiates: Buy | $274 | $229.24 | +19.53% | 1 | May 30, 2024 | |
BAX Baxter International | Initiates: Neutral | $36 | $32.85 | +9.59% | 1 | May 30, 2024 | |
SOLV Solventum | Initiates: Sell | $54 | $51.60 | +4.65% | 1 | May 30, 2024 | |
ZBH Zimmer Biomet Holdings | Initiates: Neutral | $129 | $106.27 | +21.39% | 1 | May 30, 2024 | |
MDT Medtronic | Initiates: Sell | $83 | $77.37 | +7.28% | 1 | May 30, 2024 | |
GEHC GE HealthCare Technologies | Initiates: Neutral | $87 | $76.33 | +13.98% | 1 | May 30, 2024 |
Boston Scientific
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $76.55
Upside: +17.57%
Edwards Lifesciences
May 30, 2024
Initiates: Buy
Price Target: $107
Current: $91.23
Upside: +17.29%
Stryker
May 30, 2024
Initiates: Neutral
Price Target: $372
Current: $334.30
Upside: +11.28%
Intuitive Surgical
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $438.81
Upside: +13.94%
Abbott Laboratories
May 30, 2024
Initiates: Buy
Price Target: $121
Current: $103.20
Upside: +17.25%
Becton, Dickinson and Company
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $229.24
Upside: +19.53%
Baxter International
May 30, 2024
Initiates: Neutral
Price Target: $36
Current: $32.85
Upside: +9.59%
Solventum
May 30, 2024
Initiates: Sell
Price Target: $54
Current: $51.60
Upside: +4.65%
Zimmer Biomet Holdings
May 30, 2024
Initiates: Neutral
Price Target: $129
Current: $106.27
Upside: +21.39%
Medtronic
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $77.37
Upside: +7.28%
GE HealthCare Technologies
May 30, 2024
Initiates: Neutral
Price Target: $87
Current: $76.33
Upside: +13.98%